Aura Biosciences, Inc. AURA Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -95.6%-39.3pp | -73.5%-27.5pp | -64.3%-13.3pp | -55.4%-10.3pp | -56.2%-15.8pp | |
| Return on invested capital | -160.7%-94.4pp | -96.5%-40.5pp | -76.8%-11.4pp | -81.8%-25.2pp | -66.3%-18.1pp | |
| Liquidity | ||||||
| Current ratio | 7.1×-4.0× | 8.1×-2.6× | 9×-3.4× | 12.4×-6.2× | 11.1×-10.9× | |
| Leverage | ||||||
| Debt-to-equity | 0.2×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×+0.1× | |
| Per Share | ||||||
| Book value per share | $1.59-37.7% | $2.27-25.9% | $2.38-32.4% | $3.01-22.1% | $2.55-39.5% | |
| Valuation | ||||||
| Market capitalization | $709.23M+89.4% | $346.09M-15.7% | $383.9M-13.1% | $406.13M+8.4% | $294.32M-24.0% | |
| Price / book | 6.6×+3.7× | 2.5×-0.2× | 2.5×-0.1× | 2.3×+0.4× | 2.3×+0.4× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Aura Biosciences, Inc.'s ratios come from?
- Every ratio is computed from Aura Biosciences, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.